How about Zhanjiang Kang Min Pharmaceutical Co., Ltd.?

Zhanjiang Kang Min Pharmaceutical Co., Ltd. is a limited liability company (wholly owned by natural persons), registered in Zhanjiang City, Guangdong Province, with the registration number of 1984- 1 12. Its registered address is located at Rooms 05, 06 and 10, Floor A, Yinlong Plaza, No.35 Leshan East Road, Zhanjiang Economic and Technological Development Zone.

The unified social credit code/registration number of Zhanjiang Kang Min Pharmaceutical Co., Ltd. is 91440 800194381832J, and the enterprise is in the opening state.

The business scope of Zhanjiang Kang Min Pharmaceutical Co., Ltd. is: wholesale (valid until May 23, 2024): Chinese patent medicines, chemical preparations, antibiotic raw materials, antibiotic preparations, biochemical drugs, biological products (except vaccines), protein assimilation preparations and peptide hormones; Wholesale: Class III medical devices (valid until 20211.2, specifically subject to the project operation approved by the US Food and Drug Administration of Guangdong Exhibition. 20 160069); Wholesale: Class II medical devices (specifically, the project management approved according to the No.2 Document of Equipment Management of the US Food and Drug Administration in Guangdong and Zhanjiang) 20 160 138, and the filing certificate of Class II medical device management); Business information consultation (excluding consulting business involving pre-approval and monopoly control, such as securities and futures investment consultation); Enterprise management consulting. In Guangdong Province, the total registered capital of companies with similar business scope is 556 1.78 million yuan, and the main capital is concentrated in 275 enterprises with the scale of1-50 million or above. In the province, the registered capital of enterprises is good at present.

Zhanjiang Kang Min Pharmaceutical Co., Ltd. invested in 0 companies and 3 branches.

See more information and materials of Zhanjiang Kang Min Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.